Ceapro Inc.
CRPOF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $724 | $2,152 | $1,997 | $2,349 |
| - Cash | $9 | $14 | $8 | $5 |
| + Debt | $2 | $3 | $3 | $3 |
| Enterprise Value | $718 | $2,140 | $1,992 | $2,346 |
| Revenue | $10 | $19 | $17 | $15 |
| % Growth | -48.9% | 9.6% | 13.7% | – |
| Gross Profit | $4 | $11 | $10 | $8 |
| % Margin | 37% | 58.5% | 56.3% | 50.4% |
| EBITDA | -$4 | $8 | $5 | $4 |
| % Margin | -39.8% | 40% | 27.5% | 26.7% |
| Net Income | -$5 | $4 | $3 | $2 |
| % Margin | -48.9% | 23.3% | 19.6% | 12.3% |
| EPS Diluted | -0.06 | 0.056 | 0.043 | 0.024 |
| % Growth | -207.5% | 30.8% | 79.8% | – |
| Operating Cash Flow | -$4 | $7 | $4 | $4 |
| Capital Expenditures | -$1 | -$0 | -$1 | -$1 |
| Free Cash Flow | -$5 | $6 | $3 | $4 |